RQA membership is a great way to connect with your QA colleagues.
More information
Join the community - networking, discussion and more. Open to all.
More information
Could you write an interesting article for the RQA community?
More informationInternational regulators and WHO: support healthcare professionals to enhance public confidence in COVID-19 vaccines EMA has endorsed a statement for healthcare professionals jointly developed by the International Coalition of Medicines Regulatory Authorities (ICMRA) and the World Health Organization (WHO). The statement is aimed to help healthcare professionals answer questions about the role of regulators in the oversight of COVID-19 vaccines and to reassure medical staff about the safety of COVID-19 vaccines that undergo a robust scientific evaluation to determine their quality, safety and efficacy.
Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 16-19 May 2022
Press Release: ICH Assembly Hybrid Meeting in Athens, May 2022
MHRA Board Meeting held in public - now available to book (webinar)
MHRA - March 2022 Freedom of Information Responses from the MHRA
International Clinical Trials Day
MRC prizes 2022: Nominations are now open
UKRI budget allocation confirmed
ANSM issues revised French GVPs
Analytical Procedures for mRNA Vaccine Quality (Draft Guidelines) Type of Posting: General Announcement Posting Date: 10–Feb–2022 Input Deadline: 30–Jun–2022 Expert Committee: Biologics Monograph 3 – Complex Biologics & Vaccines Proposed Title: Analytical Procedures for mRNA Vaccine Quality (Draft Guidelines)